The survey of medical device leaders confirmed industry loss during the COVID-19 pandemic, including delayed product launches and reduced sales, the release said. Increased demand from ASCs drove the need for device companies to reorganize field team responsibilities.
Those surveyed also said the pandemic has required leaders to adapt to a new normal and incorporate digital and remote technologies, the release said. More than half of respondents said they expect business to return to normal by the end of the second quarter of next year.
“The pandemic has turned the concept of access on its head for many industries. We’ve listened closely to the needs of the medical device industry to enable efficient remote access for training and case support,” Jennifer Fried, CEO of ExplORer Surgical, said in the release. “The forced changes have left the partners we work with in awe of digital solutions, and we aren’t surprised by the notion that these tools are here for the long haul.”
Read more here.
More articles on devices:
HCA launches AR spine surgery program at 2nd, 3rd Florida hospitals
2 CEOs on orthopedic consolidation — Don’t grow for the sake of growth alone
175+ spine, orthopedic surgeons on the move in 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.